Concord Biotech Limited has informed the Exchange about General Updates-Change in KMPs authorisation for determining materiality of event and information to the stock exchanges
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech Limited has informed the stock exchange about an internal change in its Key Managerial Personnel authorization structure. Specifically, the company has updated which KMPs are authorized to determine whether an event or piece of information is material enough to be disclosed to the stock exchanges. This is a routine corporate governance and compliance-related update required under SEBI's Listing Regulations. No financial numbers, transactions, or business-specific events are involved in this filing. The change does not affect the company's ongoing operations, financials, or any commercial agreements.
This is a routine governance and regulatory compliance update with no material impact on the company's financials, business, or shareholders' interests.